Titan Medical Inc (TMDIF)

[pointofreturn]

Interesting, however I am not sure it makes much sense.

Firstly, you cannot value a company with zero revenue or earnings as you did at 5 X’s. You mention 5 times earnings, but Titan has none. When you forward forecast something like this, you use earnings (not cash in the bank only, which is incorrect) and then multiply the cash by 5 X’s. The cash is not revenue and does not grow.

Secondly, Titan has $40 million in cash, not $30 million.

Hang tight a few more days and I will give you my version of a valuation. I have reviewed many different U.S. reports on ISRG, TRXC and others. I have also had extensive talks with the analysts on both buy and sell side to understand how they value companies like this.

I used this information to come up with a model based on the potential of Titan getting their FDA. I will explain the forward revenue model before I discount it as well.

Stay tuned as it’s on its way in the next few days.